Post-marketing Study of Lyophilized Nasal Spray Live Attenuated Influenza Vaccine

Clinical trial NCT06280144 · UNKNOWN

Trial details

NCT number: NCT06280144
Sponsor: Changchun BCHT Biotechnology Co.
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Influenza Prevention

Start date: 2023-09-22
Primary completion: 2024-06-30
Enrollment: 6080

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.